Nirsevimab 90% effective at preventing RSV hospitalizations in infants, CDC reports University of Minnesota Twin Cities
Source link
Nirsevimab 90% effective at preventing RSV hospitalizations in infants, CDC reports University of Minnesota Twin Cities
Source link